Document is current

Article History

Received: 15 May 2025

Accepted: 9 November 2025

First Online: 21 November 2025

Declarations

:

: FP, ACam, PG, and SM received funding from Almirall S.A. RB, ACar, and JG are employees at Almirall S.A. CC and JC are consultants of Axentiva Solutions S.L., which received consultancy fees from Almirall S.A. and, during the conduct of this study, from other pharmaceutical companies in unrelated projects.

: FP, ACam, PG, and SM participated in the review and validation of the clinical and economic inputs, structure, and assumptions for the model, as well as in the interpretation of the results and the manuscript review process. RB, ACar and JG participated in the project conceptualization, administration, supervision and manuscript review. SLH, CC and JC participated in the project conceptualization, administration, supervision, methodology, analysis, and manuscript drafting and review. All authors read and approved the final manuscript and consented to publish this study.

: The data used in this study is publicly available in the corresponding studies referenced in the article or available upon reasonable request to the corresponding author.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.